--Shanghai Fosun Pharmaceutical Group Co. is one of the shortlisted bidders competing for Novartis AG assets valued at $2 billion, Bloomberg reports, citing unnamed sources.

--The assets include Novartis's U.S. dermatology business, according to Bloomberg, with Apollo Global Management LLC, CVC Capital Partners and Aurobindo Pharma Ltd. among the companies selected to make offers.

Full story: https://bloom.bg/2I8TWUG

Write to Barcelona editors at barcelonaeditors@dowjones.com

(END) Dow Jones Newswires

May 11, 2018 02:56 ET (06:56 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Novartis Charts.
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Novartis Charts.